← Overview

Strategic Lens

Pharma and health: India and Egypt

First country

Second country

In 2025, India sold USD 58.4 million of pharmaceutical products to Egypt.

Benefits

  • BothTwo-way trade in pharmaceutical products grew 66 percent, from USD 35.2 million in 2019 to USD 58.4 million in 2025.

Constraints

  • BothFlows are one-sided: in 2025, India sold USD 58.4 million of pharmaceutical products, and Egypt sold almost none.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

India's exports to Egypt: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by India

2019: 35.1Low 24.3 / High 58.42025: 58.4

201935.1
202024.3
202133.5
202239.1
202333.5
202442.7
202558.4

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

India's imports from Egypt: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by India

2019: 0Low 0 / High 9.62025: 0

20190
20200.1
20219.6
20220
20230
20240
20250

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

More on this relationship

Benefits

  • BothRanbaxy has an Egyptian subsidiary for pharmaceutical formulations.

Sources: Wikipedia: Egypt–India relations (revision of 22 August 2026)

← India and Egypt